Skip to content
MedsAcross

Medicine

CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) 75 mg/5 mL oral solution

Clindamycin palmitate · Oral · Rising Pharma Holdings
Available on requestPrescription onlyUS FDA

CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) 75 mg/5 mL oral solution is a prescription medicine containing Clindamycin palmitate for oral use, marketed by Rising Pharma Holdings, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Storage as on the product label

Key facts

Active ingredient (INN)
Clindamycin palmitate
Brand
CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)
Strength
75 mg/5 mL
Dosage form
Oral solution
Route
Oral
Packs
100 mL
Marketing authorisation holder
Rising Pharma Holdings
Manufacturers
Rising Pharma HoldingsBryant Ranch Prepack
Origin register
US FDA, United States
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
11 September 2012
Identifiers
RxCUI 562266DailyMed set ID 3afe52c2-b65b-40fe-b2fa-da39f1bcf529, 0800afad-e4cd-4f70-aaa1-a14547be4729, 28ba03fd-0f9c-49c6-9bfb-cda5417801c6NDC 63629-2391, 64980-511, 72162-1809Application ANDA201821

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
100 mL in 1 bottle64980-511-10Rising Pharma Holdings12 June 2019
100 mL in 1 bottle63629-2391-1Bryant Ranch Prepack23 February 2021
100 mL in 1 bottle72162-1809-1Bryant Ranch Prepack3 April 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAApprovedDrugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Clindamycin palmitate 75 mg/5 mL oral solution.

Compare all 2

Other strengths and forms of Clindamycin palmitate

Clinical summary

Clindamycin palmitate is a lincosamide antibacterial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. It is available as oral solution and powder for oral solution. MedsAcross supplies Clindamycin palmitate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Clindamycin palmitate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) 75 mg/5 mL oral solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.